Jan 13, 2020 / 06:00PM GMT
Gavin Scott - JP Morgan Chase & Co, Research Division - Analyst
Let me get this presentation started. I'm Gavin Scott. I work on Cory Kasimov's team here at JPMorgan. We're going to have NovoCure present. Let me introduce their Executive Chairman, Bill Doyle. Bill.
William F. Doyle - NovoCure Limited - Executive Chairman
Good morning, everyone. Thanks, Gavin. Thanks, JPMorgan, and thank you all for your interest in NovoCure. If you're interested in our forward-looking statements, you can go to our website, you could read them in great detail. But otherwise, let me jump in.
Tumor Treating Fields cancer therapy was invented by Professor Yoram Palti at the Technion 20 years ago. And in the 20 years since he invented Tumor Treating Fields, at NovoCure, we have built a platform around that invention, where, by which, we are working to deliver Tumor Treating Fields therapy to patients to treat some of the most difficult forms of cancer. I'm going to talk a little bit about the platform this morning.
But essentially, we've created a global
Novocure Ltd at JPMorgan Healthcare Conference Transcript
Jan 14, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers